MyAverix Finance MyAverix Finance

HM · Other

VERTEX PHARMACEUTIC (VX1)

Other

VERTEX PHARMACEUTIC (VX1) is listed on HM in the Other sector. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for VX1

P/E ratio
18.00

VERTEX PHARMACEUTIC (VX1) — FAQ

What is VX1's P/E ratio?

The price-to-earnings (P/E) ratio for VERTEX PHARMACEUTIC (VX1) is 18.00 (data as of 2026-05-24).

Does VERTEX PHARMACEUTIC pay a dividend?

Dividend yield is not available in the current snapshot for VERTEX PHARMACEUTIC (VX1). Check the MyAverix Finance app for the latest dividend data.

What sector is VERTEX PHARMACEUTIC in?

VERTEX PHARMACEUTIC (VX1) is classified in the Other sector.

What exchange is VX1 listed on?

VX1 is listed on HM.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Apple Inc (APC) Microsoft Corporation (MSF)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play